相关实验视频

Updated: Jul 2, 2025

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

通过质谱测量用于癌症免疫疗法的免疫类药物的新兴潜力

Yuriko Minegishi¹, Yoshimi Haga¹, Koji Ueda¹

¹Cancer Proteomics Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan.

|February 21, 2024

概括

使用质谱和多组学,免疫组学识别瘤特异性抗原 (TSA) 和癌症免疫治疗的预测标记,提高治疗疗效.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分析化学分析化学

背景情况:

癌症免疫疗法,包括采用T细胞疗法,癌症疫苗和免疫检查点封锁 (ICB),显示出有希望的结果,但在许多患者中有效性有限.
识别强大的瘤特异性抗原 (TSA) 和预测标记物对于推进癌症免疫疗法至关重要.
由人类白细胞抗原 (HLA) 类I呈现的免疫是抗瘤免疫反应的关键媒介.

研究的目的:

审查用于癌症免疫治疗的免疫类药物的技术进步.
探索免疫类药物在识别TSA和预测标记物的潜在和未来方向.
突出质谱 (MS) 和多态学方法在这个领域的作用.

主要方法:

使用跨学科的多学科方法来发现癌症免疫组.
使用质谱法 (MS) 来识别自然处理和呈现的TSA候选物.
利用深度/机器学习支持的类搜索算法来增强免疫组学分析.

主要成果:

多组学方法扩大了对TSA的搜索空间.
质谱学灵敏度的进步提高了检测能力.
机器学习算法已经显著提升了免疫学.

结论:

免疫类药物是识别TSA和癌症免疫治疗中的预测标记物的强大工具.
分析技术和算法的持续进步将进一步增强该领域.
这种方法具有显著的潜力,可以改善患者对癌症治疗的反应.

关键词:

癌症免疫疗法免疫疗法免疫类药物免疫类药物质谱测量质谱测量质谱测量质谱测量质量测量质谱测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量新抗原是一种新抗原.

更多相关视频

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on: August 2, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Peptide Identification Using Tandem Mass Spectrometry

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...